SK

Sean Kearney

Executive Leader | Investor/Builder/Scaler of Technology Businesses | Driving AI-Powered Healthcare Innovation

Ann Arbor, Michigan

Overview 

Sean Kearney is an Executive Leader with a strong background in driving AI-powered healthcare innovation, currently serving as the Chief Executive Officer of UBERDOC, Inc. He has held key leadership roles in companies like Ruya AI and Genomenon, Inc., showcasing expertise in financial management and strategic business growth. Kearney's career highlights include serving as the Chief Financial Officer at Ruya AI and Genomenon, Inc., as well as being a Managing Director at Fosun and Three Leaf Ventures, demonstrating a track record of successfully scaling technology businesses and fostering strategic alliances within the healthcare industry.

Work Experience 

  • Chief Executive Officer

    2025 - Current

  • Advisor

    2024

Upswing Health provides a new way to conveniently deliver orthopedic care.

Raised $5,000,000.00 from Connecticut Innovations, Sidecar Angels, World Trading Inovation WTI GmbH, Ikigai Asset Management and Montage Ventures.

  • Advisor

    2021

  • Chief Financial Officer

    2024 - 2025

  • Chief Financial Officer

    2022 - 2024

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.

Raised $38,234,963.00 from University of Michigan, Riverine Ventures, Beringea, Atain, Michigan Angel Fund, Spring Mountain Capital, Green Park & Golf Ventures, Red Cedar Ventures, Michigan Rise and Invest Detroit Ventures.

  • Chief Financial Officer

    2019 - 2021

  • Advisor & Partner

    2018 - 2019

Narrow Gauge Ventures invests in passionate entrepreneurs who build companies that take advantage of this dramatic change.

  • Managing Director

    2017 - 2018

  • Managing Director

    2013 - 2017

    Cofounded and managed venture stage investment fund, from thesis and deal generation through portfolio management of 13 companies and over 30 financing events with successful exits via IPO and acquisition in genomics and telemedicine platforms.

  • Member Board Of Directors

    2016 - 2017

Articles About Sean

Relevant Websites